These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6219901)

  • 1. Biliary excretion of piperacillin.
    Taylor EW; Poxon V; Alexander-Williams J; Jackson D
    J Int Med Res; 1983; 11(1):28-31. PubMed ID: 6219901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy of biliary tract infections. XIV. Biliary excretion and gallbladder tissue levels of piperacillin (author's transl)].
    Tanimura H; Saito T; Sekiya T; Kobayashi N; Hikasa Y
    Jpn J Antibiot; 1981 Oct; 34(10):1401-9. PubMed ID: 6460883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Piperacillin: pharmacokinetic studies on the biliary and renal excretion (author's transl)].
    Baier R; Puppel H; Zelder O; Zehner R
    Arzneimittelforschung; 1981; 31(5):857-61. PubMed ID: 6456008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperacillin distribution into bile, gallbladder wall, abdominal skeletal muscle, and adipose tissue in surgical patients.
    Russo J; Thompson MI; Russo ME; Saxon BA; Matsen JM; Moody FG; Rikkers LF
    Antimicrob Agents Chemother; 1982 Sep; 22(3):488-92. PubMed ID: 6215894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary concentrations of piperacillin in patients undergoing cholecystectomy.
    Giron JA; Meyers BR; Hirschman SZ
    Antimicrob Agents Chemother; 1981 Feb; 19(2):309-11. PubMed ID: 6214990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of biliary excretion of piperacillin-tazobactam in humans.
    Westphal JF; Brogard JM; Caro-Sampara F; Adloff M; Blicklé JF; Monteil H; Jehl F
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1636-40. PubMed ID: 9257733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of bile diffusion of piperacillin].
    Brogard JM; Jehl F; Paris-Bockel D; Blickle JF; Arnaud JP; Monteil H
    Presse Med; 1986 Dec; 15(46):2332-5. PubMed ID: 2949279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Excretion in bile and clinical study of T-1220 (piperacillin) in biliary tract diseases (author's transl)].
    Saito T; Yamada Y
    Jpn J Antibiot; 1977 Oct; 30(10):835-9. PubMed ID: 592486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of biliary tract infections (XXIV). Biliary excretion and gallbladder tissue levels of mezlocillin].
    Kobayashi N; Tanimura H; Huang WF; Sekiya T; Takahashi H; Sato T; Yoshida K; Hikasa Y
    Jpn J Antibiot; 1984 Apr; 37(4):597-604. PubMed ID: 6471380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract.
    van den Hazel SJ; de Vries XH; Speelman P; Dankert J; Tytgat GN; Huibregtse K; van Leeuwen DJ
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2658-60. PubMed ID: 8913485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative biliary excretion of mezlocillin and 12 other beta-lactam antibiotics (author's transl)].
    Comte F; Brogard JM; Kopferschmitt J; Dorner M; Lavillaureix J
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):353-60. PubMed ID: 6460975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on tissue concentrations of cefoperazone and piperacillin classified by the site of the wall of gallbladder and concentration of piperacillin in the bile after operation].
    Shima K; Ueno K; Ooto T; Shima Y; Miyata T; Sei T; Yonemura Y; Uemura T; Takano N
    Jpn J Antibiot; 1984 Jun; 37(6):966-72. PubMed ID: 6492387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary pharmacokinetic profile of piperacillin: experimental data and evaluation in man.
    Brogard JM; Jehl F; Blickle JF; Dorner M; Arnaud JP; Monteil H
    Int J Clin Pharmacol Ther Toxicol; 1990 Nov; 28(11):462-70. PubMed ID: 2272706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Excretion of antibiotics into bile and urine in patients with external cholecystostomy done in order to treat obstructive jaundice].
    Hidaka K; Yamamoto H; Harada S; Katano M; Fujiwara H; Mizoguchi T; Hisatsugu T; Yamaoka K; Kisu T
    Jpn J Antibiot; 1988 Sep; 41(9):1295-303. PubMed ID: 3241327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of temocillin biliary excretion and gallbladder bile concentration in healthy subjects.
    Maudgal DP; Lanzini A; Northfield TC; Bridges C; Joseph AE
    Drugs; 1985; 29 Suppl 5():146-50. PubMed ID: 4029019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary concentrations of temocillin.
    Spelsberg F; Bauernfeind A; Wiest W; Hanser P
    Drugs; 1985; 29 Suppl 5():122-7. PubMed ID: 4029015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary concentrations of temocillin.
    Poston GJ; Greengrass A; Moryson CJ
    Drugs; 1985; 29 Suppl 5():140-5. PubMed ID: 4029018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The biliary excretion of azlocillin].
    Düben W; Helwing E; Tettenborn D; Förster D; Pütter J
    Fortschr Med; 1979 Mar; 97(9):419-21. PubMed ID: 428879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of temocillin in the treatment of biliary sepsis.
    Uwaydah M; Vartivarian S; Harakeh H; Awdeh A; Najjar F
    Drugs; 1985; 29 Suppl 5():186-90. PubMed ID: 4029024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinical study on cefotiam with special reference to excretion in bile and concentration in gallbladder tissue].
    Nishimura O; Kohno K; Sumikawa M; Kawamura Y; Hisaki T; Odachi T; Ogawa H; Kishi K; Koga S
    Jpn J Antibiot; 1984 Feb; 37(2):219-28. PubMed ID: 6330391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.